Literature DB >> 16153356

[Management of type 2 diabetic patients in primary care in Spain].

Jaime Arroyo1, Xavier Badía, Hermenegildo de la Calle, Javier Díez, Enric Esmatjes, Isabel Fernández, Claudia Filozof, Josep Franch, Gemma Gambús, Ramón Gomis, Jorge Navarro, Javier Navarro, Pedro de Pablos.   

Abstract

BACKGROUND AND
OBJECTIVE: We assess the metabolic control, complications, quality of life related to health (QLRH) and the type and amount of medical resource consumption (MRC) in type 2 diabetic patients (2DMp) followed by primary care physicians (PCP) in Spain. PATIENTS AND
METHOD: We studied 628 2DMp divided in 4 cohorts: 1. Either newly diagnosed 2DMp who required pharmacological treatment or failed to non-pharmacological measures; 2. Patients pharmacologically treated for less than 1 year; 3. Patients with pharmacological treatment for more than 1 year; 4. Patients with impaired fasting glucose (control group).
RESULTS: Eighty percent of the subjects were overweight. At baseline, 27.9, 23.5 and 36.9% of patients from cohorts 1, 2 and 3, respectively, had HbA1C < 8%. After 6 months of follow-up, 14.6, 21.3 and 22.8% of patients from cohorts 1, 2 and 3, respectively, still had "bad control". At baseline, 38.0%, 21.2% and 20.7% of patients from cohorts 1, 2, and 3, respectively, had "bad lipid profile". After 6 months, 57.4%, 54.2% and 45.3% of cohorts 1, 2 and 3, respectively, still had plasma cLDL levels > 130 mg/dl. Complications were more frequent in cohort 3. During the 6-month period, MRC was higher among 2DMp than controls (p < 0.05) and higher among patients from cohort 3 (p < 0.05) compared with all the other patients. More diabetic than control patients and more patients from cohort 3 than patients from cohort 1 and 2 reported that their expected quality of life would be better without diabetes.
CONCLUSIONS: One out of four of diabetic patients studied had HbA1C and lipids higher than the limits suggested by guidelines. Type 2 diabetes is associated with higher MRC and worse QLRH. This situation is worse among long-term diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153356     DOI: 10.1157/13077139

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  6 in total

1.  [Assessment of glycosylated hemoglobin in capillary blood compared to venous blood].

Authors:  José María Ferreras Amez; Elisa Aldea Molina; Noelia Ortega Jiménez; Laia Guardia Sancho; María Antonia Gámez Gómez; Mariano Blasco Valle
Journal:  Aten Primaria       Date:  2009-05-29       Impact factor: 1.137

2.  Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia.

Authors:  Lucas Mengual; Pilar Roura; Marta Serra; Montserrat Montasell; Gemma Prieto; Sandra Bonet
Journal:  Cardiovasc Diabetol       Date:  2010-03-29       Impact factor: 9.951

3.  Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain).

Authors:  Irene Vinagre; Manel Mata-Cases; Eduard Hermosilla; Rosa Morros; Francesc Fina; Magdalena Rosell; Conxa Castell; Josep Franch-Nadal; Bonaventura Bolíbar; Didac Mauricio
Journal:  Diabetes Care       Date:  2012-02-16       Impact factor: 19.112

4.  Family physician and endocrinologist coordination as the basis for diabetes care in clinical practice.

Authors:  Alejandra Duran; Isabelle Runkle; Pilar Matía; Maria P de Miguel; Sofia Garrido; Emilio Cervera; Maria D Fernandez; Pilar Torres; Tomas Lillo; Patricia Martin; Lucio Cabrerizo; Nuria Garcia de la Torre; Jose R Calle; Jose Ibarra; Aniceto L Charro; Alfonso L Calle-Pascual
Journal:  BMC Endocr Disord       Date:  2008-07-31       Impact factor: 2.763

5.  Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain.

Authors:  Nicole Rae Yurgin; Kristina Secnik Boye; Tatiana Dilla; Núria Lara Suriñach; Xavier Badia Llach
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

6.  Variability in the Control of Type 2 Diabetes in Primary Care and Its Association with Hospital Admissions for Vascular Events. The APNA Study.

Authors:  Sara Guillen-Aguinaga; Luis Forga; Antonio Brugos-Larumbe; Francisco Guillen-Grima; Laura Guillen-Aguinaga; Ines Aguinaga-Ontoso
Journal:  J Clin Med       Date:  2021-12-14       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.